Sort
64,565 grants matching “drug discovery”
The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling
$987,731Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2014 · DA
Efficient patient-specific cell generation by image-guidance
$987,686Shih-Jong J Lee · Drvision Technologies, Llc · R44 · FY2012 · HL
Optimization of novel pyranopyridine efflux pump inhibitors
$987,681Timothy J Opperman · Microbiotix, Inc · R44 · FY2019 · AI
Developmental Biology and Solid Tumor
$987,656Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2018 · CA
Developmental Biology and Solid Tumor
$987,654Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2017 · CA
Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of
$987,616Stig K. Hansen · Carmot Therapeutics, Inc. · R44 · FY2013 · CA
Selection and preclinical development of a bacteria-targeting, non-antibiotic lead candidate to improve cancer chemotherapy outcomes
$987,570Ward Peterson · Symberix, Inc. · R44 · FY2019 · CA
Preclinical development of Novo29, a new antibiotic
$987,424Losee Lucy Ling · Novobiotic Pharmaceuticals, Llc · R44 · FY2020 · AI
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Project 2: Preclinical Model for Antiepileptogenic Therapy Screening in Post-traumatic Epilepsy
$987,181Aristea S Galanopoulou · University Of Southern California · U54 · FY2019 · NS
Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level
$987,000Andrea Califano · Columbia University Health Sciences · R35 · FY2022 · CA
Pathobiology of Neurodegeneration in C9ORF72 Repeat Expansion
$986,853Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2017 · NS
Pathobiology of Neurodegeneration in C9ORF72 Repeat Expansion
$986,853Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2018 · NS
Biological And Biochemical Characterization Of Sigma Receptors
$986,688Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2016 · DA
Low-Cost Platform for Ultrasensitive Fluorescent Immunoblot
$986,651Scott L Crick · Auragent Bioscience, Llc · R44 · FY2024 · GM
Therapy Against Recalcitrant C. albicans Infection
$986,559Thomas A Dahl · Arietis · R44 · FY2010 · AI
Targeting Epigenetic Circuits in B-Cell Lymphomas
$986,490Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2019 · CA
Drug Discovery from Slow Growing and Rare Microbial Species
$986,467Amy Lynn Spoering · Novobiotic Pharmaceuticals, Llc · R44 · FY2014 · AI
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$986,350Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS
$986,268University Of Utah · P01 · FY2000 · GM
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance
$986,128Bryan E. Welm · University Of Utah · U01 · FY2020 · CA
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$986,054Justin Kawika Ichida · University Of Southern California · R01 · FY2024 · NS
Center for Computational Mass-Spectrometry
$985,859Pavel A Pevzner · University Of California, San Diego · P41 · FY2008 · RR
KL4 Surfactant to Mitigate Radiation-Induced Lung Injury
$985,783Robert Segal · Windtree Therapeutics, Inc. · R44 · FY2016 · AI
Biophysical mechanisms of gating and modulation in voltage-gated ion channel superfamily
$985,622Baron Chanda · Washington University · R35 · FY2022 · NS
Novel Small-Molecule Therapies for CF
$985,620Alan S Verkman · University Of California, San Francisco · P30 · FY2018 · DK